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In 1977 Zapol and colleagues reported that the pulmonary circulation was injured in 
patients with ARDS, leading to elevated pulmonary vascular resistance and pulmonary 
hypertension [1]. The investigators suggested that the pathogenesis was related to competition 
between alveolar distending pressure and blood flow in these patients who were ventilated 
with high airway pressure [2], as proposed by West et al. [3]. Pulmonary vascular remodeling 
also occurs with muscularization of normally non-muscularized arteries. Subsequently, using 
transesophageal echocardiography (TEE), Vieillard-Baron et al. reported 24 years later an 
incidence of acute cor pulmonale (ACP) of 25% during the first three days in 75 ARDS 
patients treated with lung protective ventilation [4]. A few years later, the same group 
reported a much higher incidence of 50% in more severe ARDS patients, all exhibiting a 
PaO2/FiO2 less than 100 mmHg [5]. The same group studied more than 300 patients and 
found that the incidence of ACP was strongly related to elevated plateau airway pressure with 
a safe limit for the right ventricle of 27 cmH20 [6]. Since then several questions have been 
unresolved including: What is the actual incidence of ACP in a larger population? Which are 
the main variables associated with ACP? What is the impact of ACP on prognosis, if any? 
Should RV function be monitored, and if so how? Should clinicians adjust the ventilatory 
strategy to RV function? Recently published clinical studies provide answers to some of these 
questions.  
In 2012, Guervilly et al. performed an evaluation of right ventricular (RV) function 
using TEE in a small series of 16 patients with persistent ARDS and a PaO2/FiO2 < 150 
mmHg. Patients were ventilated in volume control mode with a mean tidal volume of 6.6 
mL/kg, a mean plateau pressure of 25 cmH20 and a mean PEEP of 13 cmH20 [7]. They found 
that 56% of patients had RV dysfunction (isolated and moderate RV dilatation), whereas 25% 
had RV failure (major RV dilatation or paradoxical septal motion) [7].  
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More recently, Boissier et al. reported an incidence of ACP of 22% (95% confidence 
interval 16-27%) in a prospective single-center study of 226 patients using TEE within the 
first 3 days following diagnosis of ARDS [8]. All patients met the Berlin definition criteria for 
moderate to severe ARDS [9]. Patients were also ventilated in a volume control mode, with a 
tidal volume of 6 mL/kg, a plateau pressure < 30 cmH20 and a PEEP of 8-9 cmH20 [8]. In a 
multivariate logistic regression, independent factors associated with ACP were an infection as 
a cause of lung injury and the driving pressure (17 cmH20 in patients with ACP versus 14 
cmH20 in the others) [8]. The driving pressure is the distending pressure related to tidal 
volume and then depends on tidal volume (i.e. the ventilatory strategy), and also on 
compliance of the respiratory system (i.e. the severity of injury). Infection as a factor 
associated with ACP is interesting. As discussed in the paper by Boissier et al., circulating 
cytokines may contribute to myocardial dysfunction [8]. In addition, inflammation, including 
infection, is an important component of vascular remodeling in chronic pulmonary 
hypertension. In the acute setting, vasoconstrictors may be more important, but inflammation 
may also enhance pulmonary vasoconstriction [10]. In the study by Boissier et al., the 
consequences of ACP on hemodynamics included a significant increase in heart rate, a 
decrease in systemic blood pressure and the need for hemodynamic support [8]. More 
importantly, ACP was independently associated with 28-day mortality and in-hospital 
mortality, as well as the McCabe and Jackson class, another cause of lung injury than 
aspiration, driving pressure (per cmH20) and an elevated plasma lactate (per mmol/l) [8]. 
In another large prospective multicenter study of 200 patients with moderate to severe 
ARDS, Lhéritier et al. found a similar incidence of ACP (23%, 95% confidence interval 17-
29%) [11]. The only factor independently associated with ACP was a PaCO2 ≥  60 mmHg. 
Data on the driving pressure was not available [11]. This result is also interesting because a 
few years ago Mekontso-Dessap et al. suggested in a small series of very severe ARDS 
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patients that increased PaCO2 had a major deleterious effect on RV function [12]. Vieillard-
Baron et al. also suggested the same result in 2001 [4]. Hypercapnia is a vasoconstrictor of the 
pulmonary circulation [13]. Elevated PaCO2 can be a consequence of the ventilatory strategy 
and severity of lung injury, as suggested by the strong impact of an elevated pulmonary dead 
space fraction on prognosis [14]. Also, based on the results of the study by Lhériter et al., 
monitoring RV function by transesophageal echocardiography was much more effective than 
transthoracic echocardiography [11]. Finally, this study indicated that ACP was not associated 
with mortality [11]. Why were the results of this study different than results of the study by 
Boissier et al? In the study by Lhéritier et al., almost half of the patients with ACP were 
ventilated in the prone position, compared to only 32% of patients without ACP [11]. It has 
been clearly reported that lung protective ventilation in the prone position decreases plateau 
airway pressure [15]. In a cohort of more than 300 patients Jardin et al. suggested that effect 
of ACP on prognosis depends in part on plateau airway pressure with a safe limit at 27 cmH20 
[6]. 
These results prompt us to recommend that clinicians consider monitoring RV 
function using TEE in moderate to severe ARDS patients and to adapt the therapeutic lung 
protective ventilation strategy according to the function of the right ventricle. This can be 
considered an “RV  protective  approach”  - as illustrated in the Figure. Recently, in a 
randomized clinical trial comparing supine to prone positioning (PROSEVA), Guerin et al. 
reported a large beneficial effect of prone position on reducing mortality in severe and 
persistent ARDS with a PaO2/FiO2 < 150 mmHg [16]. The prone positioning may have been 
effective in part because of the beneficial effects on the pulmonary circulation and the right 
ventricle. Prone position may be an ideal protective approach for improving the function of 
the RV because it corrects hypoxemia without increasing PEEP and it decreases the PaCO2 
and plateau airway pressure by recruiting collapsed lung zones. This result can be contrasted 
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with the  “open-lung” approach, as represented by high-frequency oscillation ventilation 
(HFO), which worsened mortality, with more circulatory failure and a higher vasopressor 
requirement [17], perhaps reflecting increased RV dysfunction and failure, as shown by 
Guervilly et al. [7]. In HFO ventilation, airway pressure remains significantly elevated during 
all the respiratory cycle. 
However, some issues remain unclear. Do we need to turn patients to the prone 
position with ACP, even though PaO2/FiO2 is still > 150 mmHg? Could inflammation-driven 
pulmonary vasoconstriction be a therapeutic target to reduce injury to the pulmonary 
microcirculation, for example with novel therapeutics such as mesenchymal stromal cells or 
other anti-inflammatory therapies such as statins [18]? What is the effect of isolated RV 
dilatation without paradoxical septal motion and is it predictive of imminent ACP/RV failure? 
How should the level of PEEP be adjusted in individual ARDS patients, providing that the 
plateau airway pressure is maintained below 27 cmH2O? Some preliminary data suggest that 
the effect of PEEP on the pulmonary circulation and RV function depends on the balance 
between recruitment and overdistension induced by application of PEEP [12]. And finally, 
would the RV protective approach, as presented in the Figure, have a beneficial survival 
effect compared to a more conventional approach? Further clinical and experimental studies 
will be needed to address these questions.       
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Legend for the Figure: Proposed approach to preventing acute cor pulmonale and limiting its 
consequences: a right ventricular protective approach.   
RR: respiratory rate; RV right ventricular; HME: heat and moisture exchanger; PP: prone 
positioning; PEEP: positive end-expiratory pressure 
* avoid any intrinsic PEEP  
** replace HME by a heated humidifier 
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Plateau pressure < 27 cmH2O 
Driving pressure < 17 cmH2O   No 
Yes 
Decrease tidal volume 
PaCO2 < 60 mmHg 
Yes 
No 
Increase RR* 
Remove HME** 
Adapt PEEP to RV function 
and plateau pressure 
RV dysfunction  
Decrease PEEP 
No RV dysfunction 
Increase PEEP but recheck 
Consider PP at day 2 if PaO2/FiO2 < 150 mmHg 
Step 1 
Step 2 
Step 3 
Step 4 
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